ConductScience.org, home

Paper37001025

Synthesis and Characterization of Phenylalanine Amides Active against Mycobacterium abscessus and Other Mycobacteria.

Lang M and 12 others. J Med Chem, 2023. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Synthesis and Characterization of Phenylalanine Amides Active against Mycobacterium abscessus and Other Mycobacteria. Papers, record 37001025. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37001025

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and Characterization of Phenylalanine Amides Active against Mycobacterium abscessus and Other Mycobacteria.
PubMed
Journal
J Med Chem
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.79
iCite
Revised in PubMed
2026-01-27
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lang MMarkus
2Ganapathy USUday S
3Mann LLea
4Abdelaziz RRana
5Seidel RWRüdiger Whttps://orcid.org/0000-0003-3438-4666
6Goddard RRichardhttps://orcid.org/0000-0003-0357-3173
7Sequenzia IIlaria
8Hoenke SSophie
9Schulze PPhilipp
10Aragaw WWWassihun Wedajo
11Csuk RRenéhttps://orcid.org/0000-0001-7911-290X
12Dick TThomas
13Richter AAdrianhttps://orcid.org/0000-0002-0062-7896

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mycobacterium abscessusMajor topic
Mycobacterium Infections, NontuberculousMajor topic
Mycobacterium tuberculosisMajor topic
Animals
Amides
Anti-Bacterial Agents
Mammals
Microbial Sensitivity Tests
Aniline Compounds
Morpholines
Thiophenes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI132374NIAID NIH HHSUnited StatesR01AI132374PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1292744931,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.Eur J Med Chem2018https://conductscience.org/library/papers/29274493PubMed
214653732Aromatic hydroxylation by cytochrome P450: model calculations of mechanism and substituent effects.J Am Chem Soc2003https://conductscience.org/library/papers/14653732PubMed
334312062Mycobacterium abscessus.Trends Microbiol2021https://conductscience.org/library/papers/34312062PubMed
418187888Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.J Gen Appl Microbiol2007https://conductscience.org/library/papers/18187888PubMed
530909391Mycobacterium abscessus: Environmental Bacterium Turned Clinical Nightmare.Microorganisms2019https://conductscience.org/library/papers/30909391PubMed
625140958Multidrug-resistant tuberculosis and culture conversion with bedaquiline.N Engl J Med2014https://conductscience.org/library/papers/25140958PubMed
725299873The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review.Int J Tuberc Lung Dis2014https://conductscience.org/library/papers/25299873PubMed
828011608Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.Clin Infect Dis2017https://conductscience.org/library/papers/28011608PubMed
936222275Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated Resistance.Angew Chem Int Ed Engl2022https://conductscience.org/library/papers/36222275PubMed
10108225413-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT): a new coupling reagent with remarkable resistance to racemization.Org Lett1999https://conductscience.org/library/papers/10822541PubMed
1135478222Anti-tuberculosis treatment strategies and drug development: challenges and priorities.Nat Rev Microbiol2022https://conductscience.org/library/papers/35478222PubMed
1233826327
Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.
J Med Chem2021https://conductscience.org/library/papers/33826327PubMed
1325278573Microbiological features and clinical relevance of new species of the genus Mycobacterium.Clin Microbiol Rev2014https://conductscience.org/library/papers/25278573PubMed
1434259925Racemization-free synthesis of Nα-2-thiophenoyl-phenylalanine-2-morpholinoanilide enantiomers and their antimycobacterial activity.Amino Acids2021https://conductscience.org/library/papers/34259925PubMed
1524304206Metal-free coupling of saturated heterocyclic sulfonylhydrazones with boronic acids.J Org Chem2014https://conductscience.org/library/papers/24304206PubMed
1628396540Rifabutin Is Active against Mycobacterium abscessus Complex.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28396540PubMed
1727084892Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015.Drug Metab Dispos2016https://conductscience.org/library/papers/27084892PubMed
1827518757Synthesis and proapoptotic activity of oleanolic acid derived amides.Bioorg Chem2016https://conductscience.org/library/papers/27518757PubMed
1932781595General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus.J Clin Med2020https://conductscience.org/library/papers/32781595PubMed
2036377951In Vitro Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus.Microbiol Spectr2022https://conductscience.org/library/papers/36377951PubMed

See all 65 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42227659Cytochrome P450-Mediated Metabolism of Antimycobacterial Nα-Aroyl-N-aryl-phenylalanine Amides.ACS Infect Dis2026https://conductscience.org/library/papers/42227659PubMed
41463692Current Advances in Developing New Antimicrobial Agents Against Non-Tuberculous Mycobacterium.Antibiotics (Basel)2025https://conductscience.org/library/papers/41463692PubMed
41339746Transcription co-inhibition alters drug resistance evolution and enhances Mycobacterium tuberculosis clearance from granulomas.Nat Microbiol2026https://conductscience.org/library/papers/41339746PubMed
40149109A Simple In Vitro Method to Determine Bactericidal Activity Against Mycobacterium abscessus Under Hypoxic Conditions.Antibiotics (Basel)2025https://conductscience.org/library/papers/40149109PubMed
39360834Toward better cures for Mycobacterium abscessus lung disease.Clin Microbiol Rev2024https://conductscience.org/library/papers/39360834PubMed
389676333-[(Benzo-1,3-dioxol-5-yl)amino]-4-methoxycyclobut-3-ene-1,2-dione: polymorphism and twinning of a precursor to an antimycobacterial squaramide.Acta Crystallogr C Struct Chem2024https://conductscience.org/library/papers/38967633PubMed
38786132Broad-Spectrum In Vitro Activity of Nα-Aroyl-N-Aryl-Phenylalanine Amides against Non-Tuberculous Mycobacteria and Comparative Analysis of RNA Polymerases.Antibiotics (Basel)2024https://conductscience.org/library/papers/38786132PubMed
38329388Synthesis and in vitro Metabolic Stability of Sterically Shielded Antimycobacterial Phenylalanine Amides.ChemMedChem2024https://conductscience.org/library/papers/38329388PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37001025

GET https://conductscience.org/api/papers/v1/37001025/references?page=2